1515 — China Resources Medical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$4.82bn
- HK$7.29bn
- CNY10.11bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 541 | 418 | 270 | 242 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -12 | -99.8 | 216 | 163 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -227 | 212 | 40.7 | -111 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 366 | 644 | 710 | 627 | — |
Capital Expenditures | -36.4 | -210 | -227 | -253 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 194 | 270 | -1,709 | 310 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 157 | 60.4 | -1,936 | 57.3 | — |
Financing Cash Flow Items | 17.5 | -23.8 | -29.7 | -47.5 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -41 | -7.38 | 846 | -33.2 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 482 | 695 | -377 | 653 | — |